301 related articles for article (PubMed ID: 17403934)
1. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.
Loeser S; Loser K; Bijker MS; Rangachari M; van der Burg SH; Wada T; Beissert S; Melief CJ; Penninger JM
J Exp Med; 2007 Apr; 204(4):879-91. PubMed ID: 17403934
[TBL] [Abstract][Full Text] [Related]
2. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
[TBL] [Abstract][Full Text] [Related]
3. Ablation of Cbl-b provides protection against transplanted and spontaneous tumors.
Chiang JY; Jang IK; Hodes R; Gu H
J Clin Invest; 2007 Apr; 117(4):1029-36. PubMed ID: 17364027
[TBL] [Abstract][Full Text] [Related]
4. Control of virus-specific CD8+ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection.
Ou R; Zhang M; Huang L; Moskophidis D
J Virol; 2008 Apr; 82(7):3353-68. PubMed ID: 18199651
[TBL] [Abstract][Full Text] [Related]
5. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.
Goetz B; An W; Mohapatra B; Zutshi N; Iseka F; Storck MD; Meza J; Sheinin Y; Band V; Band H
Oncotarget; 2016 Aug; 7(32):51107-51123. PubMed ID: 27276677
[TBL] [Abstract][Full Text] [Related]
6. The role of the e3 ligase cbl-B in murine dendritic cells.
Wallner S; Lutz-Nicoladoni C; Tripp CH; Gastl G; Baier G; Penninger JM; Stoitzner P; Wolf D
PLoS One; 2013; 8(6):e65178. PubMed ID: 23762309
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
[TBL] [Abstract][Full Text] [Related]
8. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin E3 ligase Cbl-b in T cells tolerance and tumor immunity.
Loeser S; Penninger JM
Cell Cycle; 2007 Oct; 6(20):2478-85. PubMed ID: 17704644
[TBL] [Abstract][Full Text] [Related]
10. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
[TBL] [Abstract][Full Text] [Related]
11. Cbl-b deficiency provides protection against UVB-induced skin damage by modulating inflammatory gene signature.
Singh TP; Vieyra-Garcia PA; Wagner K; Penninger J; Wolf P
Cell Death Dis; 2018 Aug; 9(8):835. PubMed ID: 30082827
[TBL] [Abstract][Full Text] [Related]
12. Establishment of the major compatibility complex-dependent development of CD4+ and CD8+ T cells by the Cbl family proteins.
Huang F; Kitaura Y; Jang I; Naramura M; Kole HH; Liu L; Qin H; Schlissel MS; Gu H
Immunity; 2006 Oct; 25(4):571-81. PubMed ID: 17045823
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
[TBL] [Abstract][Full Text] [Related]
14. The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.
St Rose MC; Qui HZ; Bandyopadhyay S; Mihalyo MA; Hagymasi AT; Clark RB; Adler AJ
J Immunol; 2009 Oct; 183(8):4975-83. PubMed ID: 19801520
[TBL] [Abstract][Full Text] [Related]
15. T cell specific deletion of Casitas B lineage lymphoma-b reduces atherosclerosis, but increases plaque T cell infiltration and systemic T cell activation.
Vos WG; van Os BW; den Toom M; Beckers L; van Roomen CPAA; van Tiel CM; Mohapatra BC; Band H; Nitz K; Weber C; Atzler D; de Winther MPJ; Bosmans LA; Lutgens E; Seijkens TTP
Front Immunol; 2024; 15():1297893. PubMed ID: 38504977
[TBL] [Abstract][Full Text] [Related]
16. Overproduction of IFNγ by Cbl-b-Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity.
Han S; Liu ZQ; Chung DC; Paul MS; Garcia-Batres CR; Sayad A; Elford AR; Gold MJ; Grimshaw N; Ohashi PS
Cancer Immunol Res; 2022 Apr; 10(4):437-452. PubMed ID: 35181779
[TBL] [Abstract][Full Text] [Related]
17. Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity.
Shamim M; Nanjappa SG; Singh A; Plisch EH; LeBlanc SE; Walent J; Svaren J; Seroogy C; Suresh M
J Immunol; 2007 Dec; 179(11):7233-43. PubMed ID: 18025165
[TBL] [Abstract][Full Text] [Related]
18. Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
Gómez-Martín D; Ibarra-Sánchez M; Romo-Tena J; Cruz-Ruíz J; Esparza-López J; Galindo-Campos M; Díaz-Zamudio M; Alcocer-Varela J
Arthritis Rheum; 2013 Apr; 65(4):1032-42. PubMed ID: 23280105
[TBL] [Abstract][Full Text] [Related]
19. T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency.
Teh CE; Daley SR; Enders A; Goodnow CC
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14709-14. PubMed ID: 20668237
[TBL] [Abstract][Full Text] [Related]
20. Cbl-b gene silencing in splenic T lymphocytes as a therapeutic strategy to target the prostate cancer RM-1 cell tumors in immune competent mice.
Shi ZD; Li XF; Hao L; Zhao Y; Wang YX; Dong BZ; Chen WH; Zhang ZG; Wang YM; Fu Q; Han CH; Li S
Eur Rev Med Pharmacol Sci; 2014; 18(24):3819-30. PubMed ID: 25555872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
